Growth papered over; execution clarity elusive on NGDS trials

₹1,153 Cr revenue YoY +12.4%, but PAT down -1.4% YoY; QoQ collapse: revenue -7.8%, PAT -23.5%

Realization at 180+, but product mix was unfavorable this quarter; FX down ₹40 Cr QoQ and freight pass-through inflated top line

OPM 26.4% (delivered), operating margin ~27% per call. Q1 below Q4, attributed to FX loss ₹40 Cr and trial expenses.

Trials ongoing, timeline uncertain (3 months to 2 years); South America second trial 'may take longer than anticipated'; no revenue or volume visibility

Current 430-440K tons, running at 60-65K/quarter (~65-70% utilization). Capex revised UP to ₹350-400 Cr (from ₹130 Cr) for HQ land + expansion, ROI unclear.

Prior: ₹165/kg guidance (FY26). Current: ₹180+/kg realized, but company declines to revise, citing FX/freight/mix volatility. Tacit acknowledgment that realization is temporary.

Asked on 280-290K tons target; management: 'frankly, no specific answer.' Trials unclear, conversion timing opaque. Clear guidance miss vs prior year's 'robust guidance.'

FY27 CapEx ₹130 Cr → ₹350-400 Cr (HQ ₹170-200 Cr, land ₹50-100 Cr). No corresponding revenue/return targets. Signals capital constraint before NGDS clarity.

NGDS 'not sold standalone,' bundled only. TAM 1-1.5M tons (unchanged). No new revenue stream, only margin via bundling. Solution-stickiness benefit, not scale.

Still work in progress; may take longer than anticipated due to technicalities. Trials are iterative and uncertain in timeline (3 months to 2 years).

Sold per-kg, bundled with media + liners. No new pricing model. TAM remains 1-1.5M tons (unchanged). Part of solution, not standalone product.

No. 165 was based on FY26 conditions. Current 180 reflects FX, freight, mix—all volatile. Cannot commit to higher number without visibility.

Frankly, no specific answer. Trials are work in progress. Once we have perfect clarity, we will give guidance. Currently maintaining status quo.

LatAm is 1M-ton market, others are smaller. 30-40% of 1.5M-ton opportunity is LatAm. Concentrating effort there for needle-moving returns. Other geographies are welcome but not priority.

QoQ. FX gain down ₹40 Cr (₹65 Cr Q4 → ₹25 Cr Q1). Realization + freight pass-through higher, but other expenses also higher. Net: neutral on gross margin (60-61% consistent).

Ghana: dialogue with govt, slow mode. China: small lab, exploring options. No timeline. LatAm plant premature; need local ecosystem, customer trials first. India remains base for now.

Supply going well. 3-3.5K tons per quarter. Will continue. Good progress. But don't expect to quantify adjacent mine impact yet; still at trial stage.

Capacity (430-440K tons) built in advance. Can scale to 70-75% easily (300-350K tons annually). Waiting for NGDS conversions to drive volume. Surplus capacity is intentional.

Holding cash for NGDS execution. No buyback/dividend near-term. Once trials show traction and reach optimum, board will decide on capital allocation. 'At least a few more quarters.'

Q1: ₹50 Cr (₹30 solar, ₹20 maintenance). FY27: HQ land/building ₹170-200 Cr (this year), additional land ₹50-100 Cr for brownfield/greenfield. Final split in Q2.

Freight still elevated, dropping from peak. RM (ferrochrome) on higher side. Passing through via realization. Not worried; manageable via pricing mechanism.

Management declined to commit on 280-290K tons target. Said status quo maintenance. Implied ₹1,200+ Cr annually (60-65K/quarter × 4 × 180/kg).

Management states 'our guidance continues at 20%.' Q1 at 27%, above range. Q4 at 27.8-27.9%, also above. Range may be floor, not central case.

HQ land/bldg ₹170-200 Cr, additional land ₹50-100 Cr, debottlenecking/maintenance ₹30-50 Cr. Split between capex and land invest unclear. ROI unquantified.

South America trials 'work in progress,' may take 2+ years. No volume guidance. If trials fail, ₹350-400 Cr capex and opportunity cost (delayed growth) realized. Core business flat without conversions.

Realization 180+/kg driven by FX tailwind (₹85 → ₹95 per USD), freight pass-through, and product mix. FX swing of ₹10 per kg = -₹65-70 Cr revenue if reverted. Management refuses to revise guidance, signaling lack of confidence in sustainability.

430-440K tons capacity, 60-65K/quarter run rate = 65-70% utilization. ₹350-400 Cr capex to add more capacity without clear demand catalyst. If NGDS trials miss, excess capacity becomes cost drag.

Asked on 280-290K FY27 tonnage: 'frankly, no specific answer.' NGDS commercialization promised mid-2026 in prior calls; now 'uncertain 3-24 months.' Analyst trust deteriorating. Future equity raises or acquisitions may face skepticism.

Chinese forged producers (20+ companies) dominate commodity segment (Chile using Chinese media). High-chrome segment remains protected (custom, solution-led), but only 10-15% of total TAM. Margin erosion risk if high-chrome mix declines.